Seeking Alpha

Amgen (AMGN) CEO Kevin Sharer will retire in May and be replaced by company President and COO...

Amgen (AMGN) CEO Kevin Sharer will retire in May and be replaced by company President and COO Robert Bradway. RBC Capital analyst Michael Yee says the biotech's new CEO will need to "reinvigorate a focus of innovation for new products and a focus on cutting expenses." Are both those possible? (PR)
Comments (1)
  • yes! hire news of the world hacks to hack the phones of research teams of other co's.

     

    pressers work cheaper than phd's. theft has always been an innovative and cost effective way of finding new products.

     

    ha!
    16 Dec 2011, 07:17 AM Reply Like
DJIA (DIA) S&P 500 (SPY)